This is example text for design purposes...Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt.
NWHN Policy Advocacy Director Sarah Christopherson provides a top-level overview of the ACA, how it helped women gain comprehensive health coverage, some exciting advances made in the Biden COVID relief package, and what challenges and opportunities lies ahead.
We’re excited to make progress on COVID relief, the ACA, and more, but deeply shaken by yesterday’s violent insurrection, incited by the president of the United States.
The FDA says pregnant people can meet with their doctors remotely and have their abortion at home — but first, they must travel during a global pandemic just to pick up their pills.
This research brief examines some of the most common waiver provisions attempted by states and spells out what each means for women as advocates and policymakers work to close the coverage gap.
On September 28 — the 20th anniversary of FDA’s approval of the abortion pill — we held a socially distanced protest in front of FDA headquarters and delivered the names of all 12,000+ of our petition signers.
In brazen disregard of their own stated principles, Senate Republicans are ramming through an illegitimate Court nomination with the election on the line.
Public comments urging the FDA’s Office of Women’s Health to ensure that women’s needs are represented across FDA and in the agency’s research, education, and public outreach.
Patients are turning to telehealth appointments and online pharmacies for routine medical care during the COVID-19 outbreak without having to leave their homes. But for most pregnant people seeking safe and effective abortion pills, the FDA has created a Byzantine set of rules that delay or block access to care.
The FDA says pregnant people can meet with their doctors remotely and have their abortion at home — but first, they must travel during a global pandemic just to pick up their pills.
Should we be thrilled that conservatives are embracing over-the-counter access for birth control? When something seems too good to be true, it usually is.
Sarah Christopherson was the NWHN’s Policy Advocacy Director from 2016 to 2021, responsible for directing the organization’s legislative, regulatory, and judicial advocacy efforts and managing the policy team. She served as the NWHN’s primary issue area expert on federal health reform implementation and defense, drug and device safety and efficacy, and sexual and reproductive health. She also directed federal policy initiatives for Raising Women’s Voices (RWV). She was quoted on behalf of the NWHN in the New York Times, Washington Post, CNN, USA Today, Reuters, Cosmopolitan, Rewire, Prevention, Yahoo News, Vice, ABC News San Francisco, and other print, TV, and radio outlets.
Prior to joining the NWHN, Sarah worked for Congress from 2005 to 2015, including serving as the Washington Director/Legislative Director to Congresswoman Niki Tsongas (D-MA), where she directed the Member’s legislative agenda and supervised her DC-based staff of eight. Over the course of her career, Sarah staffed every issue area that comes before the federal government, with in-depth knowledge of health policy, tax policy, financial services and banking, consumer protection, and the federal budget. Her experience includes work on the Affordable Care Act, Medicaid, Medicare, reproductive health, and the impact of banking and tax policy on income inequality, among other areas. Her legislative accomplishments include provisions enacted into law in the Dodd-Frank Wall Street Reform and Consumer Protection Act, Small Business Innovation Research reauthorization, and multiple National Defense Authorizations. She has a Bachelor of Science degree in political science and a Bachelor of Arts degree in history from Arizona State University and a Master of Arts degree in foreign policy from George Washington University.
